Stay Updated
Press Releases
Pharma's $50 Billion Tax Windfall For Investors
KEY POINT: “The large buyback programs are rolling out while the same pharmaceutical companies raise drug prices and while Americans struggle to afford their prescriptions.” AXIOS / Bob Herman / Feb. 22, 2018 “The pharmaceutical industry is using a large portion of its windfall from Republicans’ corporate tax cuts to boost its stock prices. Nine […]
Press Releases
New analysis shows CAR-T drug wildly overpriced
WASHINGTON, DC — A new analysis by cancer patients and experts at Brigham and Women’s Hospital/Harvard Medical School shows that Novartis’ CAR-T drug, Kymriah, is overpriced by at least $315,000 per treatment. The in-depth analysis, published today on the Health Affairs Blog, factors in Novartis’ research and development costs, production cost, royalties, patient assistance programs, […]
Press Releases
Patients For Affordable Drugs Hosts Training with Coloradans Fighting for Lower Drug Prices
DENVER, CO — Patients For Affordable Drugs brought together more than two dozen Coloradans this Saturday in Denver for a training focused on how to effectively organize, mobilize, and fight for lower drug prices at the state level. Patients For Affordable Drugs (P4AD), a bipartisan national patient organization, has heard stories from more than 320 […]
Press Releases
Patients For Affordable Drugs Reacts to President Trump’s Promise to Lower Drug Prices
WASHINGTON, DC — David Mitchell, a patient with incurable blood cancer and the President of Patients For Affordable Drugs, issued the following statement in response to President Donald Trump’s promise to lower drug prices during his State of the Union address: “Patients are watching. We are angry and hurting. And we plan to hold the […]
Press Releases
Donald Trump Should Keep His Promise to Lower Drug Prices
WASHINGTON, DC — In advance of tonight’s State of the Union address, Patients For Affordable Drugs Executive Director Ben Wakana issued the following statement: “Donald Trump made a campaign pledge to lower drug prices, a promise that gave hope to millions of Americans struggling to afford prescription drugs. It’s time the Trump administration put words […]
Press Releases
Momentum Building for Bipartisan CREATES Act
WASHINGTON, DC — Organizations representing patients and the research and development community today sent a letter urging Congressional leaders to pass the CREATES Act. Friends of Cancer Research, the National Multiple Sclerosis Society, and Patients For Affordable Drugs encouraged Congress to act soon to pass the bipartisan legislation that will help drive down drug prices […]
Press Releases
Statement on Luxturna’s $850,000 Price Tag
WASHINGTON, DC — The following statement was issued by David Mitchell, a patient with incurable blood cancer and the president and founder of Patients For Affordable Drugs, regarding the announcement of an $850,000 price tag for Luxturna, a new treatment that can correct a defective gene responsible for blindness in a small number of Americans. […]
Press Releases
Cancer Patients Dying Due to High Yescarta Price
WASHINGTON, DC — The following statement was issued by David Mitchell, a patient with incurable blood cancer and the president of Patients For Affordable Drugs, regarding reports of patients dying while waiting to receive Gilead’s $373,000 cancer drug, Yescarta. “My heart is breaking for these patients and their families. This situation is tragic, infuriating, and […]